• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过捕获技术揭示乳腺癌细胞中 HDAC1 底物和相关蛋白的差异谱。

Differential profiles of HDAC1 substrates and associated proteins in breast cancer cells revealed by trapping.

机构信息

Department of Chemistry, Wayne State University, Detroit, MI, USA.

出版信息

Mol Omics. 2021 Aug 9;17(4):544-553. doi: 10.1039/d0mo00047g.

DOI:10.1039/d0mo00047g
PMID:33885658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8355046/
Abstract

Histone deacetylase (HDAC) proteins, which regulate the acetylation state of proteins, are the targets of multiple clinical drugs for cancer treatment. Due to the heterogeneity of tumors, HDAC proteins play different roles in the progression of various cancer types. For example, MDA-MB-468 and MDA-MB-231 cells are both triple negative breast cancer cells but belong to different subtypes that display different response to HDAC inhibitor drugs. To investigate the role of HDAC proteins in breast cancer, the substrate and associated proteins of HDAC1 in MDA-MB-231, MDA-MB-468, and a normal breast epithelial cell line, MCF10A, were analyzed using substrate trapping mutants and proteomics-based mass spectrometry. All three cell lines demonstrated nonoverlapping substrate protein profiles. While both normal MCF10A and cancerous MDA-MB-468 cell lines contained similar HDAC1 associated proteins, including proteins associated with epigenetic and RNA processing mechanisms, the HDAC1 associated protein profile of MDA-MB-231 cells was devoid of expected epigenetic proteins. The variable associated protein profiles of MDA-MB-231 and MDA-MB-468 suggest that HDAC1 plays distinct roles in breast cancer cell biology, which might affect cancer aggressiveness and HDAC inhibitor sensitivity.

摘要

组蛋白去乙酰化酶(HDAC)蛋白调节蛋白质的乙酰化状态,是多种癌症治疗临床药物的作用靶点。由于肿瘤的异质性,HDAC 蛋白在各种癌症类型的进展中发挥不同的作用。例如,MDA-MB-468 和 MDA-MB-231 细胞均为三阴性乳腺癌细胞,但属于不同亚型,对 HDAC 抑制剂药物的反应不同。为了研究 HDAC 蛋白在乳腺癌中的作用,使用底物捕获突变体和基于蛋白质组学的质谱法分析了 MDA-MB-231、MDA-MB-468 和正常乳腺上皮细胞系 MCF10A 中 HDAC1 的底物和相关蛋白。这三种细胞系均表现出非重叠的底物蛋白谱。虽然正常 MCF10A 和癌性 MDA-MB-468 细胞系均含有相似的 HDAC1 相关蛋白,包括与表观遗传和 RNA 处理机制相关的蛋白,但 MDA-MB-231 细胞系的 HDAC1 相关蛋白谱缺乏预期的表观遗传蛋白。MDA-MB-231 和 MDA-MB-468 的可变相关蛋白谱表明,HDAC1 在乳腺癌细胞生物学中发挥独特的作用,这可能影响癌症的侵袭性和 HDAC 抑制剂的敏感性。

相似文献

1
Differential profiles of HDAC1 substrates and associated proteins in breast cancer cells revealed by trapping.通过捕获技术揭示乳腺癌细胞中 HDAC1 底物和相关蛋白的差异谱。
Mol Omics. 2021 Aug 9;17(4):544-553. doi: 10.1039/d0mo00047g.
2
Proteomics-based trapping with single or multiple inactive mutants reproducibly profiles histone deacetylase 1 substrates.基于蛋白质组学的单一或多种失活突变体捕获可重复性地上调组蛋白去乙酰化酶 1 的底物谱。
J Proteomics. 2023 Mar 15;274:104807. doi: 10.1016/j.jprot.2022.104807. Epub 2022 Dec 29.
3
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.组蛋白去乙酰化酶抑制剂诱导的有丝分裂停滞由Eg5/KIF11乙酰化介导。
Cell Chem Biol. 2017 Apr 20;24(4):481-492.e5. doi: 10.1016/j.chembiol.2017.03.008. Epub 2017 Apr 6.
4
HDAC1 Substrate Profiling Using Proteomics-Based Substrate Trapping.基于蛋白质组学的底物捕获法对 HDAC1 底物进行分析。
ACS Chem Biol. 2018 Dec 21;13(12):3315-3324. doi: 10.1021/acschembio.8b00737. Epub 2018 Dec 10.
5
Homeobox Protein PROX1 Expression is Negatively Regulated by Histone Deacetylase 1 and c-JUN Complex in MDA-MB-231 Human Breast Cancer Cells.转录因子 PROX1 的表达受组蛋白去乙酰化酶 1 和 c-JUN 复合物的负调控,PROX1 是 MDA-MB-231 人乳腺癌细胞中的一种。
Folia Biol (Praha). 2023;69(3):81-90. doi: 10.14712/fb2023069030081.
6
[Isoform Selectivity of HDAC Inhibitors Has a Significant Effect on PD-L1 Expression in the Triple-negative Cancer Cell Line MDA-MB-231].[组蛋白去乙酰化酶抑制剂的亚型选择性对三阴性癌细胞系MDA-MB-231中程序性死亡受体配体1表达有显著影响]
Yakugaku Zasshi. 2022;142(4):431-437. doi: 10.1248/yakushi.21-00213.
7
Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.人乳腺癌中maspin的亚细胞定位与组蛋白去乙酰化酶1表达相关。
Anticancer Res. 2017 Sep;37(9):5071-5077. doi: 10.21873/anticanres.11924.
8
HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.HDAC6 抑制通过微管蛋白乙酰化增强三阴性乳腺癌细胞中埃博霉素的抗肿瘤作用。
Breast Cancer Res Treat. 2021 Feb;186(1):37-51. doi: 10.1007/s10549-020-06033-2. Epub 2021 Jan 16.
9
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.用组蛋白去乙酰化酶抑制剂 panobinostat 靶向三阴性乳腺癌细胞。
Breast Cancer Res. 2012 May 21;14(3):R79. doi: 10.1186/bcr3192.
10
Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.以DW22双重靶向视黄酸X受体和组蛋白去乙酰化酶作为一种新型抗肿瘤方法。
Oncotarget. 2015;6(12):9740-55. doi: 10.18632/oncotarget.3149.

引用本文的文献

1
Histone acetylation modulators in breast cancer.乳腺癌中的组蛋白乙酰化调节剂
Breast Cancer Res. 2025 Mar 31;27(1):49. doi: 10.1186/s13058-025-02006-9.
2
LncRNA EGFR‑AS1 promotes lung cancer cell proliferation, invasion and metastasis via regulation of miR‑449a/HDAC1.长链非编码RNA EGFR-AS1通过调控miR-449a/HDAC1促进肺癌细胞的增殖、侵袭和转移。
Exp Ther Med. 2024 Dec 3;29(2):27. doi: 10.3892/etm.2024.12777. eCollection 2025 Feb.
3
Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment.基于数据挖掘的肺腺癌中组蛋白去乙酰化酶1表达及调控网络与靶向治疗的意义
J Oncol. 2023 Jan 4;2023:2745074. doi: 10.1155/2023/2745074. eCollection 2023.
4
miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting and expression.miR-3614-3p通过靶向并抑制 和 的表达来抑制人乳腺癌细胞的侵袭性。 (注:原文中“targeting and expression”部分缺失具体内容)
Transl Cancer Res. 2022 Jun;11(6):1565-1575. doi: 10.21037/tcr-21-2419.
5
Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients.全面分析组蛋白去乙酰化酶基因在胶质瘤患者预后和免疫浸润中的作用。
Aging (Albany NY). 2022 May 11;14(9):4050-4068. doi: 10.18632/aging.204071.
6
HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity.使用基于蛋白质组学的底物捕获技术发现 HDAC6 的底物:HDAC6 去乙酰化 PRMT5 以影响甲基转移酶活性。
ACS Chem Biol. 2021 Aug 20;16(8):1435-1444. doi: 10.1021/acschembio.1c00303. Epub 2021 Jul 27.

本文引用的文献

1
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.
2
HDAC1 Substrate Profiling Using Proteomics-Based Substrate Trapping.基于蛋白质组学的底物捕获法对 HDAC1 底物进行分析。
ACS Chem Biol. 2018 Dec 21;13(12):3315-3324. doi: 10.1021/acschembio.8b00737. Epub 2018 Dec 10.
3
UniProt: a worldwide hub of protein knowledge.UniProt:蛋白质知识的全球枢纽。
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515. doi: 10.1093/nar/gky1049.
4
Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer.嵌合体 HDAC 抑制剂:基于 HDAC 的抗癌策略的综合评述。
Med Res Rev. 2018 Sep;38(6):2058-2109. doi: 10.1002/med.21505. Epub 2018 May 7.
5
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.LSD1 激活促进诱导性 EMT 程序,并调节乳腺癌中的肿瘤微环境。
Sci Rep. 2018 Jan 8;8(1):73. doi: 10.1038/s41598-017-17913-x.
6
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.乳腺癌细胞系分类及其与乳腺肿瘤亚型的相关性。
J Cancer. 2017 Sep 12;8(16):3131-3141. doi: 10.7150/jca.18457. eCollection 2017.
7
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.组蛋白去乙酰化酶抑制剂诱导的有丝分裂停滞由Eg5/KIF11乙酰化介导。
Cell Chem Biol. 2017 Apr 20;24(4):481-492.e5. doi: 10.1016/j.chembiol.2017.03.008. Epub 2017 Apr 6.
8
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
9
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.组蛋白去乙酰化酶抑制剂:一种有吸引力的抗乳腺癌治疗策略。
Anticancer Res. 2017 Jan;37(1):35-46. doi: 10.21873/anticanres.11286.
10
LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation.赖氨酸特异性去甲基化酶1(LSD1)的底物结合和基因表达受组蛋白去乙酰化酶1(HDAC1)介导的去乙酰化作用影响。
ACS Chem Biol. 2017 Jan 20;12(1):254-264. doi: 10.1021/acschembio.6b00776. Epub 2016 Dec 15.